News & Updates
Filter by Specialty:
Sleep irregularity measurement tied to hypertension, high BP
Hypertension and higher blood pressure (BP) levels are associated with the objective measurement of sleep irregularity, as assessed by standard deviation (SD) of sleep duration for 1 week, particularly in individuals without obstructive sleep apnoea (OSA), a study has shown.
Sleep irregularity measurement tied to hypertension, high BP
03 Apr 2023
Short nighttime sleepers at risk of long COVID, mental and CV diseases
Short nighttime sleepers are at higher risks of long COVID, depression and cardiovascular (CV) diseases than normal sleepers, according to three recent studies by researchers from the Chinese University of Hong Kong (CUHK).
Short nighttime sleepers at risk of long COVID, mental and CV diseases
03 Apr 2023
Indapamide shows low incidence of severe hypokalaemia in patients with hypertension
In a territory-wide, 12-year follow-up retrospective study by the University of Hong Kong, indapamide has demonstrated a low incidence of hospitalization for severe hypokalaemia in patients with hypertension. Use of sustained-release (SR) indapamide appears to lower the risk of severe hypokalaemia vs the immediate-release (IR) formulation.
Indapamide shows low incidence of severe hypokalaemia in patients with hypertension
30 Mar 2023
Regular virgin olive oil intake lowers mortality risk
Moderate consumption of virgin olive oil (VOO) daily appears to help reduce the risk of all-cause and cardiovascular mortality, reports a study. However, such effects are not found in common olive oil.
Regular virgin olive oil intake lowers mortality risk
29 Mar 2023
Cardiorespiratory fitness change linked to survival in patients with or without CVD
Changes in cardiorespiratory fitness (CRF) appear to predict the risk of mortality in patients with and without cardiovascular disease (CVD), suggest the results of a study.
Cardiorespiratory fitness change linked to survival in patients with or without CVD
29 Mar 2023
HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.
